electroCore, Inc. (ECOR )

Currency in USD Disclaimer
$9.55 -$3.45 (-26.54%)
Open 03/14/2025
$9.31
$11.73
$5.32
$19.49

Company brief: ELECTROCORE, INC. (ECOR )


electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

ECOR Corporation News

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

March 13, 2025 at 1:36 am ET

seekingalpha.com -- electroCore, Inc. (NASDAQ:ECOR ) Q4 2024 Results Conference Call March 12, 2025 5:30 PM ET Company Participants Dan Goldberger - CEO & Director Joshua Lev - Chief Financial Officer Conference Call Par...

electroCore Announces Full Year 2024 Financial Results

March 12, 2025 at 8:05 pm ET

globenewswire.com -- Record f ull year 2024 net sales of $ 25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCore TM   in the United States Department of Vete...

Income Statement